Jaihind Industries Limited has returned to profitability for the financial year ended March 31, 2026, reporting a net profit of ₹1.84 lakh compared to ₹1.58 lakh in the previous year. The company's revenue from operations for the year increased to ₹19.92 lakh from ₹13.55 lakh in FY25. The Board of Directors approved the audited financial results for the quarter and year ended March 31, 2026 at a meeting held on May 28, 2026.

For the fourth quarter of FY26, the company reported a net profit of ₹0.25 lakh, reversing the net loss of ₹2.70 lakh recorded in the corresponding quarter of the previous year. Revenue from operations for Q4FY26 stood at ₹5.09 lakh, up from ₹2.30 lakh in Q4FY25. The total income for the quarter was ₹5.09 lakh, while total expenses were ₹4.29 lakh.

The statutory auditors, M/s. P S V Jain & Associates, issued an audit report with an unmodified opinion on the annual audited financial results. The financial statements were prepared in compliance with the Indian Accounting Standards (Ind AS) prescribed under the Companies Act, 2013. The Board meeting commenced at 4:15 p.m. and concluded at 4:45 p.m. on May 28, 2026.

Financial Results for FY26

The company's equity share capital stood at ₹628.75 lakh as of March 31, 2026, compared to ₹851.41 lakh in the previous year. Earnings per share (EPS) for the year was ₹0.03 on a basic and diluted basis, up from ₹0.02 in FY25. The extract of the financial results was published in Active Times (English) and Mumbai Lakshwadeep (Marathi) on May 30, 2026, in accordance with Regulation 47 of the SEBI (LODR) Regulations.

Jaihind Industries Limited has incorporated a wholly-owned subsidiary named Wellness & Medicinal Oasisz Private Limited with a 78% shareholding. The subsidiary was registered with the Registrar of Companies on May 13, 2026, as per a Certificate of Incorporation. The company disclosed this information under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The newly incorporated entity operates in the healthcare and pharmaceutical industry. As it is a recently established company, it has not yet commenced business operations, and its turnover is currently nil. The registered office of Wellness & Medicinal Oasisz Private Limited is located in Mumbai, India.

Financial Details of the Subsidiary

The financial structure of the subsidiary includes an authorized and paid-up capital of ₹1,00,000. This capital is divided into 10,000 equity shares with a face value of ₹10 each. The cost of acquisition for the 78% stake was ₹78,000, which was paid through cash consideration.

Strategic Objectives

The incorporation of this subsidiary aligns with Jaihind Industries' strategy to expand its footprint in the healthcare and pharmaceutical sectors. The company aims to explore opportunities in hospital infrastructure, medical services, wellness, healthcare management, and allied activities through this new venture. Management expects this move to strengthen its long-term business portfolio and create growth opportunities within the healthcare industry.

The transaction does not fall under related party transactions, and no specific governmental or regulatory approvals were required for the acquisition. The promoter and promoter group have no interest in the transaction other than what has been disclosed.